PSMA PET AS A BIOMARKER FOR PI3K SIGNALING AXIS IN PTEN-DEFICIENT PROSTATE CANCER - NEW AWARD...CORRECTS THE 8/6/2019 ENTRY AS A FORMULA GRANT

$1,063,622FY2019Department of the ArmyDOD

Sloan-Kettering Institute For Cancer Research

Investigators

PSMA PET AS A BIOMARKER FOR PI3K SIGNALING AXIS IN PTEN-DEFICIENT PROSTATE CANCER - NEW AWARD...CORRECTS THE 8/6/2019 ENTRY AS A FORMULA GRANT · GrantIndex